Logo image of XNCR

XENCOR INC (XNCR) Stock Fundamental Analysis

USA - NASDAQ:XNCR - US98401F1057 - Common Stock

14.13 USD
-0.54 (-3.68%)
Last: 10/30/2025, 8:00:02 PM
14.25 USD
+0.12 (+0.85%)
After Hours: 10/30/2025, 8:00:02 PM
Fundamental Rating

3

Taking everything into account, XNCR scores 3 out of 10 in our fundamental rating. XNCR was compared to 534 industry peers in the Biotechnology industry. The financial health of XNCR is average, but there are quite some concerns on its profitability. XNCR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

XNCR had negative earnings in the past year.
XNCR had a negative operating cash flow in the past year.
XNCR had negative earnings in 4 of the past 5 years.
XNCR had negative operating cash flow in 4 of the past 5 years.
XNCR Yearly Net Income VS EBIT VS OCF VS FCFXNCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

XNCR has a Return On Assets of -20.23%. This is in the better half of the industry: XNCR outperforms 76.40% of its industry peers.
Looking at the Return On Equity, with a value of -28.67%, XNCR is in the better half of the industry, outperforming 78.09% of the companies in the same industry.
Industry RankSector Rank
ROA -20.23%
ROE -28.67%
ROIC N/A
ROA(3y)-14.92%
ROA(5y)-8.95%
ROE(3y)-20.68%
ROE(5y)-12.58%
ROIC(3y)N/A
ROIC(5y)N/A
XNCR Yearly ROA, ROE, ROICXNCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

XNCR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XNCR Yearly Profit, Operating, Gross MarginsXNCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

XNCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XNCR has been increased compared to 1 year ago.
The number of shares outstanding for XNCR has been increased compared to 5 years ago.
Compared to 1 year ago, XNCR has an improved debt to assets ratio.
XNCR Yearly Shares OutstandingXNCR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
XNCR Yearly Total Debt VS Total AssetsXNCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

XNCR has an Altman-Z score of 1.33. This is a bad value and indicates that XNCR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.33, XNCR is in the better half of the industry, outperforming 63.30% of the companies in the same industry.
XNCR has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
XNCR has a worse Debt to Equity ratio (0.15) than 65.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 1.33
ROIC/WACCN/A
WACC8.21%
XNCR Yearly LT Debt VS Equity VS FCFXNCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

XNCR has a Current Ratio of 5.34. This indicates that XNCR is financially healthy and has no problem in meeting its short term obligations.
XNCR has a Current ratio (5.34) which is comparable to the rest of the industry.
XNCR has a Quick Ratio of 5.34. This indicates that XNCR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of XNCR (5.34) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 5.34
Quick Ratio 5.34
XNCR Yearly Current Assets VS Current LiabilitesXNCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

XNCR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.96%, which is quite good.
The Revenue has grown by 17.52% in the past year. This is quite good.
XNCR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.75% yearly.
EPS 1Y (TTM)16.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.68%
Revenue 1Y (TTM)17.52%
Revenue growth 3Y-26.22%
Revenue growth 5Y-6.75%
Sales Q2Q%157.12%

3.2 Future

XNCR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.80% yearly.
Based on estimates for the next years, XNCR will show a very strong growth in Revenue. The Revenue will grow by 43.87% on average per year.
EPS Next Y25.63%
EPS Next 2Y7.13%
EPS Next 3Y7.32%
EPS Next 5Y11.8%
Revenue Next Year119.19%
Revenue Next 2Y40.2%
Revenue Next 3Y32.66%
Revenue Next 5Y43.87%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XNCR Yearly Revenue VS EstimatesXNCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
XNCR Yearly EPS VS EstimatesXNCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 1 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XNCR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XNCR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XNCR Price Earnings VS Forward Price EarningsXNCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XNCR Per share dataXNCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.13%
EPS Next 3Y7.32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XNCR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XENCOR INC

NASDAQ:XNCR (10/30/2025, 8:00:02 PM)

After market: 14.25 +0.12 (+0.85%)

14.13

-0.54 (-3.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners114.72%
Inst Owner Change0.12%
Ins Owners1.1%
Ins Owner Change0.93%
Market Cap1.01B
Revenue(TTM)157.07M
Net Income(TTM)-177865000
Analysts82.22
Price Target25.05 (77.28%)
Short Float %11.43%
Short Ratio6.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)18.33%
Min EPS beat(2)-7.54%
Max EPS beat(2)44.19%
EPS beat(4)3
Avg EPS beat(4)22.04%
Min EPS beat(4)-7.54%
Max EPS beat(4)44.19%
EPS beat(8)4
Avg EPS beat(8)-20.8%
EPS beat(12)7
Avg EPS beat(12)-5.59%
EPS beat(16)9
Avg EPS beat(16)85.12%
Revenue beat(2)2
Avg Revenue beat(2)77.62%
Min Revenue beat(2)55.9%
Max Revenue beat(2)99.34%
Revenue beat(4)3
Avg Revenue beat(4)75%
Min Revenue beat(4)-20.99%
Max Revenue beat(4)165.74%
Revenue beat(8)4
Avg Revenue beat(8)37.49%
Revenue beat(12)7
Avg Revenue beat(12)30.76%
Revenue beat(16)10
Avg Revenue beat(16)42.49%
PT rev (1m)0%
PT rev (3m)-15.65%
EPS NQ rev (1m)-1.5%
EPS NQ rev (3m)5.73%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)15.77%
Revenue NQ rev (1m)-2.8%
Revenue NQ rev (3m)17.73%
Revenue NY rev (1m)-0.99%
Revenue NY rev (3m)24.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.42
P/FCF N/A
P/OCF N/A
P/B 1.62
P/tB 1.65
EV/EBITDA N/A
EPS(TTM)-2.4
EYN/A
EPS(NY)-2.99
Fwd EYN/A
FCF(TTM)-1.97
FCFYN/A
OCF(TTM)-1.88
OCFYN/A
SpS2.2
BVpS8.7
TBVpS8.54
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.23%
ROE -28.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.92%
ROA(5y)-8.95%
ROE(3y)-20.68%
ROE(5y)-12.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 58.21%
Cap/Sales 4.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.34
Quick Ratio 5.34
Altman-Z 1.33
F-Score4
WACC8.21%
ROIC/WACCN/A
Cap/Depr(3y)252.19%
Cap/Depr(5y)241.55%
Cap/Sales(3y)15.72%
Cap/Sales(5y)12.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.68%
EPS Next Y25.63%
EPS Next 2Y7.13%
EPS Next 3Y7.32%
EPS Next 5Y11.8%
Revenue 1Y (TTM)17.52%
Revenue growth 3Y-26.22%
Revenue growth 5Y-6.75%
Sales Q2Q%157.12%
Revenue Next Year119.19%
Revenue Next 2Y40.2%
Revenue Next 3Y32.66%
Revenue Next 5Y43.87%
EBIT growth 1Y22.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.83%
EBIT Next 3Y11.28%
EBIT Next 5Y9.12%
FCF growth 1Y-3.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-42.14%
OCF growth 3YN/A
OCF growth 5YN/A

XENCOR INC / XNCR FAQ

Can you provide the ChartMill fundamental rating for XENCOR INC?

ChartMill assigns a fundamental rating of 3 / 10 to XNCR.


What is the valuation status for XNCR stock?

ChartMill assigns a valuation rating of 0 / 10 to XENCOR INC (XNCR). This can be considered as Overvalued.


Can you provide the profitability details for XENCOR INC?

XENCOR INC (XNCR) has a profitability rating of 1 / 10.